Pleomorphic liposarcoma arising on the cheek: a case report and review of the literature

Takahiro Suzuki, Kazuhiro Murakami, Naoya Noguchi, Fumi Shoji, Sachiko Fukaya, Yutaka Tateda, Muneharu Yamazaki, Miho Nakazumi, Teruyuki Sato, Nobuo Ohta


Pleomorphic liposarcoma, which is the rarest of the four liposarcoma types according to the World Health Organization (WHO) classification of soft tissue tumors, is associated with a high rate of recurrence and poor prognosis. In the present report, we present the case of a 69-year-old male patient with pleomorphic liposarcoma arising in the right cheek. The mass was initially considered as benign such as schwannoma due to the absence of facial nerve palsy. However, the mass grew rapidly, requiring surgical removal with facial nerve preservation. Pathological and molecular examination led to the definitive diagnosis of pleomorphic liposarcoma. The postoperative adjuvant radiotherapy was added, and there were no signs of recurrence at four-year follow-up.


H Pleomorphic liposarcoma, Cheek, Head and neck

Full Text:



Ducimetière F, Lurkin A, Ranchère-Vince D, Decouvelaere AV, Péoc’h M, Istier L et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One. 2011;6:e20294.

Reitan JB, Kaalhus O, Brennhovd IO, Sager EM, Stenwig AE, Talle K et al. Prognostic factors in liposarcoma. Cancer. 1985;55:2482-90.

Golledge J, Fisher C, Rhys-Evans PH. Head and neck liposarcoma. Cancer. 1995;76:1051-8.

Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology. 2014;46:95-104.

Downes KA, Goldblum JR, Montgomery EA, Fisher C. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol. 2001;14:179-84.

Lee ATJ, Thway K, Huang PH, Jones RL. Clinical and molecular spectrum of liposarcoma. J Clin Oncol. 2018;36:151-9.

Crago AM, Dickson MA. Liposarcoma: multimodality management and future targeted therapies. Surg Oncol Clin N Am. 2016;25:761-73.

Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381-91.

Kilpatrick SE, Doyon J, Choong PFM, Sim FH, Nascimento AG. The clinicopathologic spectrum of myxoid and round cell liposarcoma: a study of 95 cases. Cancer. 1996;77:1450-8.

Peterson JJ, Kransdorf MJ, Bancroft LW, O’Connor MI. Malignant fatty tumors: classification, clinical course, imaging appearance and treatment. Skeletal Radiol. 2003;32:493-503.

Hornick JL, Bosenberg MW, Mentzel T, McMenamin ME, Oliveira AM, Fletcher CDM. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am J Surg Pathol. 2004;28:1257-67.

Wang L, Luo R, Xiong Z, Xu J, Fang D. Pleomorphic liposarcoma: an analysis of 6 case reports and literature review. Medicine (Baltimore). 2018;97:e9986.

Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet. 2004;155:1-24.

Cho J, Lee SE, Choi Y-L. Diagnostic Value of MDM2 and DDIT3 Fluorescence in situ hybridization in liposarcoma classification: a single-institution experience. Korean J Pathol. 2012;46:115-22.

Keung EZ, Somaiah N. Overview of liposarcomas and their genomic landscape. J Transl Genet Genom. 2019;3:8.

Guillou L, Aurias A. Soft tissue sarcomas with complex genomic profiles. Virchows Arch 2010;456:201-17.

Ohta N, Watanabe T, Abe Y, Onoe Y, Ishida A, Aoyagi M. Dedifferentiated posterior cervical liposarcoma with carcinoid: report of a case. Auris Nasus Larynx. 2011;38:421-5.

Mouret P. Liposarcoma of the hypopharynx. A case report and review of the literature. Rev Laryngol Otol Rhinol. 1999;120:39-43.

Gritli S, Khamasi K, Lachkhem A, Touati S, Chorfa A, Ben MT, et al. Head and neck liposarcoma: a 32 year experience. Auris Nasus Larynx. 2010;37:347-51.

Spittle MF, Newton A, MacKenzie DH. Liposarcoma: a review of 60 cases. Br J Cancer. 1970;24:696-704.

Eeles RA, Fisher C, A’Hem RP, Robinson M, Rhys-Evans P, Henk JM, et al. Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer. 1993;68:201-7.

Agarwal J, Kadakia S, Agaimy A, Ogadzanov A, Khorsandi A, Chai RL. Pleomorphic liposarcoma of the head and neck: presentation of two cases and literature review. Am J Otolaryngol. 2017;38:505-7.

Davis EC, Ballo MT, Luna MA, Roberts DB, Nong X. Liposarcoma of the head and neck: the University of Texas MD Anderson Cancer Center experience. Head Neck. 2009;31:28-36.

Gebhard S, Coindre JM, Michels JJ, Terrier P, Bertrand G, Trassard M, et al. Pleomorphic liposarcoma: clinicopathologic, immunohisto-chemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2002;26:601-16.